Thrombolysis in acute stroke (II)

The Lancet

Volumn 385, Issue 9976, 2015, Pages 1394-1395

  Brunström, Mattias ^a   Carlberg, Bo ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPARATIVE STUDY; HUMAN; LETTER; META ANALYSIS (TOPIC); NUMBERS NEEDED TO TREAT; PRIORITY JOURNAL; RISK REDUCTION; THERAPY DELAY; TREATMENT OUTCOME; FEMALE; MALE; STROKE;

FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84928701332     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60715-2     Document Type: Letter

References (1)

1. Emberson J, Lees KR, Lyden P, et al Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929-35.